Bumetanide Injection
Product Images NDC 65219-570

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 65219-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Bum01 0000 01)

Structure (Bum01 0000 01)
Chemical structure of Bumetanide depicting a benzene ring with attached functional groups including a carboxyl group (COOH), sulfonamide group (SO2NH2), an aminobutyl side chain (CH3(CH2)3HN), and a methoxyphenyl group (OC6H5).*
FDA Label Image

Fresenius Kabi Logo (Bum01 0000 02)

FDA Label Image

Principal Display Panel – Bumetanide 1 mg/4 mL Vial Label (Bum01 0000 03)

Principal Display Panel – Bumetanide 1 mg/4 mL Vial Label (Bum01 0000 03)
Label for Bumetanide Injection, USP 1 mg/4 mL (0.25 mg/mL) by Fresenius Kabi USA, LLC. The vial is for intravenous or intramuscular use, containing benzyl alcohol preservative. It includes storage instructions (20°C to 25°C, protect from light) and manufacture details indicating Made in India, with a labeler address in Lake Zurich, IL.*
FDA Label Image

Principal Display Panel – Bumetanide 1 mg/4 mL Shelf Carton (Bum01 0000 04)

Principal Display Panel – Bumetanide 1 mg/4 mL Shelf Carton (Bum01 0000 04)
Packaging label for Bumetanide Injection, USP, 1 mg/4 mL (0.25 mg/mL) for intravenous or intramuscular use. The label indicates single-dose vials, 10 x 4 mL, manufactured by Fresenius Kabi USA, LLC. The label includes storage instructions and a barcode, with detailed ingredient amounts and preservative information.*
FDA Label Image

Principal Display Panel – Bumetanide 2.5 mg/10 mL Vial Label (Bum01 0000 05)

Principal Display Panel – Bumetanide 2.5 mg/10 mL Vial Label (Bum01 0000 05)
Label for Bumetanide Injection, USP 2.5 mg/10 mL (0.25 mg/mL) multiple-dose vial by Fresenius Kabi USA, LLC. Intended for intravenous or intramuscular use, it contains benzyl alcohol as preservative. The label includes storage instructions and manufacturing details, noting it is made in India.*
FDA Label Image

Principal Display Panel – Bumetanide 2.5 mg/10 mL Shelf Carton (Bum01 0000 06)

Principal Display Panel – Bumetanide 2.5 mg/10 mL Shelf Carton (Bum01 0000 06)
Bumetanide Injection, USP 2.5 mg/10 mL (0.25 mg/mL) packaging label for injection by Fresenius Kabi USA, LLC. The label indicates the product is for intravenous or intramuscular use, containing 10 multiple-dose vials of 10 mL each. The label includes storage instructions, ingredient details, barcode, and manufacturer information (made in India).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.